These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1931753)
1. Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations. Haapasalo H; Atkin NB; Collan Y; Pesonen E; Paljärvi L Anal Cell Pathol; 1991 Sep; 3(5):261-71. PubMed ID: 1931753 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry]. Lanza G; Maestri I; Dubini A; Gafà R Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799 [TBL] [Abstract][Full Text] [Related]
3. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study. Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612 [TBL] [Abstract][Full Text] [Related]
4. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of ploidy level in human tumours. II extra-uterine cancers and summary of data on 1171 tumours. Atkin NB Cytobios; 1976; 15(60):233-7. PubMed ID: 1035153 [TBL] [Abstract][Full Text] [Related]
6. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma. Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763 [TBL] [Abstract][Full Text] [Related]
7. Application of new ploidy-related parameters for the diagnosis of ovarian tumours. Korabiowska M; Brinck U; Skubis J; Sattler B; Fischer G Anticancer Res; 2004; 24(6):4191-4. PubMed ID: 15736472 [TBL] [Abstract][Full Text] [Related]
8. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. Kildal W; Risberg B; Abeler VM; Kristensen GB; Sudbø J; Nesland JM; Danielsen HE Eur J Cancer; 2005 May; 41(8):1127-34. PubMed ID: 15911235 [TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells. Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971 [TBL] [Abstract][Full Text] [Related]
13. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma. Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757 [TBL] [Abstract][Full Text] [Related]
14. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560 [TBL] [Abstract][Full Text] [Related]
15. [Significance of flow cytometry in the prognosis of tumors of the kidney in adults]. Sibert L; Laquerrière A; Czernichow P; Dadoun D; Hemet J; Grise P Ann Urol (Paris); 1989; 23(6):476-81. PubMed ID: 2694924 [TBL] [Abstract][Full Text] [Related]
16. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate. Meyer JS; Gersell DJ; Yim S Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140 [TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
18. Lack of prognostic significance of ploidy and S-phase measurements in advanced ovarian cancer. Coley HM; Sargent JM; Titley J; Taylor CG Anticancer Res; 1999; 19(3A):2111-6. PubMed ID: 10470157 [TBL] [Abstract][Full Text] [Related]
19. Prediction of relapse in patients with breast cancer by DNA cytometry. Machado-Santelli GM; Mori L; Pereira CA Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156 [TBL] [Abstract][Full Text] [Related]
20. Relationships between image cytometric DNA index, proliferation fraction and multiploidy and conventional nuclear grade in breast carcinoma. Smith FB; Zappi ME Mod Pathol; 1993 Sep; 6(5):606-11. PubMed ID: 7504261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]